OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators

Free Radical Biology and Medicine

Volumn 70, Issue , 2014, Pages 117-128

  Valente, Anthony J ^a   Irimpen, Anand M ^a,b   Siebenlist, Ulrich ^c   Chandrasekar, Bysani ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Atherosclerosis; Endothelial dysfunction; Free radicals; NADPH oxidases; Oxidative stress

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADIPONECTIN; CYTOPLASM PROTEIN; HIGH DENSITY LIPOPROTEIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METFORMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SHORT HAIRPIN RNA; SUPEROXIDE; TRAF3IP2 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TRAF3IP2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL DEATH; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; THORACIC AORTA; UPREGULATION; VASODILATATION; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; CELL DEATH; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, HDL3; LIPOPROTEINS, LDL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84896495983     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.02.014     Document Type: Article

References (41)

1. S. Parthasarathy, A. Raghavamenon, M.O. Garelnabi, and N. Santanam Oxidized low-density lipoprotein Methods Mol. Biol. 610 2010 403 417
2. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic. Biol. Med. 28 2000 1815 1826 (Pubitemid 30628668)
3. S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res. 40 1999 2143 2157 (Pubitemid 30017516)
4. J.L. Mehta, and D.Y. Li Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells Biochem. Biophys. Res. Commun. 248 1998 511 514 (Pubitemid 28404451)
5. T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaki An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77 (Pubitemid 27130922)
6. J. Chen, Y. Liu, H. Liu, P.L. Hermonat, and J.L. Mehta Molecular dissection of angiotensin II-activated human LOX-1 promoter Arterioscler. Thromb. Vasc. Biol. 26 2006 1163 1168 (Pubitemid 43732128)
7. T. Aoyama, T. Sawamura, Y. Furutani, R. Matsuoka, M.C. Yoshida, H. Fujiwara, and T. Masaki Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene Biochem. J. 339 Pt 1 1999 177 184 (Pubitemid 29179305)
8. A. Heinloth, K. Heermeier, U. Raff, C. Wanner, and J. Galle Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells J. Am. Soc. Nephrol. 11 2000 1819 1825
9. X. Li, M. Commane, H. Nie, X. Hua, M. Chatterjee-Kishore, D. Wald, M. Haag, and G.R. Stark Act1, an NF-kappa B-activating protein Proc. Natl. Acad. Sci. USA 97 2000 10489 10493
10. A. Leonardi, A. Chariot, E. Claudio, K. Cunningham, and U. Siebenlist CIKS, a connection to Ikappa B kinase and stress-activated protein kinase Proc. Natl. Acad. Sci. USA 97 2000 10494 10499
11. A.J. Valente, R.A. Clark, J.M. Siddesha, U. Siebenlist, and B. Chandrasekar CIKS (Act1 or TRAF3IP2) mediates angiotensin-II-induced interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy J. Mol. Cell. Cardiol. 53 2012 113 124
12. A.J. Valente, T. Yoshida, R.A. Clark, P. Delafontaine, U. Siebenlist, and B. Chandrasekar Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling Free Radic. Biol. Med. 60 2013 125 135
13. Z.J. Guo, H.X. Niu, F.F. Hou, L. Zhang, N. Fu, R. Nagai, X. Lu, B.H. Chen, Y.X. Shan, J.W. Tian, R.H. Nagaraj, D. Xie, and X. Zhang Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway Antioxid. Redox Signaling 10 2008 1699 1712
14. B. Venkatesan, A.J. Valente, N.A. Das, A.J. Carpenter, T. Yoshida, J.L. Delafontaine, U. Siebenlist, and B. Chandrasekar CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction Cell. Signalling 25 2013 359 371
15. C. Besler, T.F. Luscher, and U. Landmesser Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease EMBO Mol. Med. 4 2012 251 268
16. G.D. Norata, A. Pirillo, and A.L. Catapano Modified HDL: biological and physiopathological consequences Nutr. Metab. Cardiovasc. Dis. 16 2006 371 386 (Pubitemid 43994438)
17. V.A. Folcik, R.A. Nivar-Aristy, L.P. Krajewski, and M.K. Cathcart Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques J. Clin. Invest. 96 1995 504 510
18. S. Yla-Herttuala, M.E. Rosenfeld, S. Parthasarathy, C.K. Glass, E. Sigal, J.L. Witztum, and D. Steinberg Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions Proc. Natl. Acad. Sci. USA 87 1990 6959 6963
19. A. Pirillo, P. Uboldi, N. Ferri, A. Corsini, H. Kuhn, and A.L. Catapano Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins Biochem. Biophys. Res. Commun. 428 2012 230 233
20. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, S. Yamashita, T. Funahashi, and Y. Matsuzawa Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476 (Pubitemid 30005109)
21. B. Chandrasekar, W.H. Boylston, K. Venkatachalam, N.J. Webster, S.D. Prabhu, and A.J. Valente Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression J. Biol. Chem. 283 2008 24889 24898
22. M.H. Zou, S.S. Kirkpatrick, B.J. Davis, J.S. Nelson, W.G.t. Wiles, U. Schlattner, D. Neumann, M. Brownlee, M.B. Freeman, and M.H. Goldman Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: role of mitochondrial reactive nitrogen species J. Biol. Chem. 279 2004 43940 43951 (Pubitemid 39390702)
23. S.H. Choi, H. Yin, A. Ravandi, A. Armando, D. Dumlao, J. Kim, F. Almazan, A.M. Taylor, C.A. McNamara, S. Tsimikas, E.A. Dennis, J.L. Witztum, and Y.I. Miller Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages PLoS One 8 2013 e83145
24. R. Harkewicz, K. Hartvigsen, F. Almazan, E.A. Dennis, J.L. Witztum, and Y.I. Miller Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein J. Biol. Chem. 283 2008 10241 10251
25. A.J. Valente, T. Yoshida, R. Izadpanah, P. Delafontaine, U. Siebenlist, and B. Chandrasekar Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration: inhibition by simvastatin Cell. Signalling 25 2013 1447 1456
26. A.J. Valente, T. Yoshida, S.N. Murthy, S.S. Sakamuri, M. Katsuyama, R.A. Clark, P. Delafontaine, and B. Chandrasekar Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18 Am. J. Physiol. Heart Circ. Physiol. 303 2012 H282 H296
27. E. Claudio, S.U. Sonder, S. Saret, G. Carvalho, T.R. Ramalingam, T.A. Wynn, A. Chariot, A. Garcia-Perganeda, A. Leonardi, A. Paun, A. Chen, N.Y. Ren, H. Wang, and U. Siebenlist The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation J. Immunol. 182 2009 1617 1630
28. T. Kimura, H. Tomura, K. Sato, M. Ito, I. Matsuoka, D.S. Im, A. Kuwabara, C. Mogi, H. Itoh, H. Kurose, M. Murakami, and F. Okajima Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells J. Biol. Chem. 285 2010 4387 4397
29. E. Vasques, A.L. Almeida, V. Noya, B. D'Alegria, G. Marathe, T.M. McIntyre, E. Tibirica, P.T. Bozza, A.R. Silva, and H.C. Castro-Faria-Neto Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein Endothelium 13 2006 1 8
30. D. Li, B. Yang, and J.L. Mehta Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas Am. J. Physiol. 275 1998 H568 H576
31. M. Sata, and K. Walsh Oxidized LDL activates fas-mediated endothelial cell apoptosis J. Clin. Invest. 102 1998 1682 1689 (Pubitemid 28516253)
32. T. Aoyama, H. Fujiwara, T. Masaki, and T. Sawamura Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells J. Mol. Cell. Cardiol. 31 1999 2101 2114 (Pubitemid 30029022)
33. K. Kugiyama, S.A. Kerns, J.D. Morrisett, R. Roberts, and P.D. Henry Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins Nature 344 1990 160 162 (Pubitemid 20094133)
34. M. Yokoyama, K. Hirata, R. Miyake, H. Akita, Y. Ishikawa, and H. Fukuzaki Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein Biochem. Biophys. Res. Commun. 168 1990 301 308 (Pubitemid 20142619)
35. S. Tsimikas, J.T. Willerson, and P.M. Ridker C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients J. Am. Coll. Cardiol. 47 2006 C19 C31
36. A.F. Pasini, M. Anselmi, U. Garbin, E. Franchi, C. Stranieri, M.C. Nava, V. Boccioletti, C. Vassanelli, and L. Cominacini Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and toll-like receptor 4 in unstable angina Arterioscler. Thromb. Vasc. Biol. 27 2007 1991 1997 (Pubitemid 47312309)
37. M. Yoshikawa, N. Sakuma, T. Hibino, T. Sato, and T. Fujinami HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2 Clin. Biochem. 30 1997 221 225 (Pubitemid 27225355)
38. A.M. Gotto Jr. High-density lipoproteins: biochemical and metabolic factors Am. J. Cardiol. 52 1983 2B 4B (Pubitemid 13045215)
39. H. Kobayashi, N. Ouchi, S. Kihara, K. Walsh, M. Kumada, Y. Abe, T. Funahashi, and Y. Matsuzawa Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ. Res. 94 2004 e27 e31
40. I. Takac, K. Schroder, L. Zhang, B. Lardy, N. Anilkumar, J.D. Lambeth, A.M. Shah, F. Morel, and R.P. Brandes The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4 J. Biol. Chem. 286 2011 13304 13313
41. Z. Zhao, Y. Qian, D. Wald, Y.F. Xia, J.G. Geng, and X. Li IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation J. Immunol. 170 2003 5674 5680 (Pubitemid 36617860)